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ABSTRACT
Background: A group A Streptococcus (GAS) lineage of genotype emm3, sequence type 15 (ST15)
was associated with a 6 month upsurge in invasive GAS disease in the UK. The epidemic lineage
(Lineage C) had lost 2 typical emm3 prophages, F315.1 and F315.2 associated with the
superantigen ssa, but gained a different prophage (FUK-M3.1) associated with a different
superantigen, speC and a DNAse spd1. Methods and Results: The presence of speC and spd1 in
Lineage C ST15 strains enhanced both in vitro mitogenic and DNase activities over non-Lineage C
ST15 strains. Invasive disease models in Galleria mellonella and SPEC-sensitive transgenic mice,
revealed no difference in overall invasiveness of Lineage C ST15 strains compared with non-Lineage
C ST15 strains, consistent with clinical and epidemiological analysis. Lineage C strains did however
markedly prolong murine nasal infection with enhanced nasal and airborne shedding compared
with non-Lineage C strains. Deletion of speC or spd1 in 2 Lineage C strains identiﬁed a possible role
for spd1 in airborne shedding from the murine nasopharynx. Conclusions: Nasopharyngeal
infection and shedding of Lineage C strains was enhanced compared with non-Lineage C strains
and this was, in part, mediated by the gain of the DNase spd1 through prophage acquisition.
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Background
Group A Streptococcus (GAS) has the ability to cause a
diverse range of clinical manifestations. Periodic
upsurges in invasive GAS (iGAS) disease can occur at a
national level and are often associated with expansion of
a single genotype within the population.1-3 Although
recombination-related remodelling in the core genome
can lead to sustained expansion of GAS lineages,1 the
biologic basis for short-lived upsurges is unclear.
In the United Kingdom an upsurge in iGAS was
recorded in the 6 months between November 2008
and April 2009, prompting a public health alert.4
Analyses of the collected epidemiological data did not
identify increases in any particular risk group or
iGAS manifestation.5 A large proportion of the
upsurge could however be attributed to a marked
increase in the proportion of emm3 iGAS infections
and, more speciﬁcally to a new lineage of sequence
type (ST) 15 within the emm3 population with an
altered genomic prophage proﬁle, identiﬁed by whole
genome sequencing6 (Fig. 1). This lineage was ﬁrst
identiﬁed in the UK emm3 population in 2006 and
rapidly increased in prevalence during the upsurge
period, before declining again to be undetectable by
2013.6 Unlike typical emm3 ST15 GAS strains, ST15
strains belonging to this lineage (Lineage C) had lost
2 prophages; F315.1 with no known associated viru-
lence factors, and F315.2 that is associated with the
superantigen ssa. Lineage C strains had also gained a
different prophage (FUK-M3.1) that carried the
superantigen speC and a DNase, spd1, rarely found in
emm3 before the upsurge. Here, we report the
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phenotypic impact of this genetic change on experi-
mental and clinical disease, to better understand the
mechanisms that allow a sudden but transient emer-
gence of new lineages and periodic increases in inva-
sive infection. Interestingly, we identiﬁed that the
genetic changes that occurred in Lineage C ST15
strains compared with other ST15 Lineages, did not
impact on experimental invasiveness but notably
enhanced nasopharyngeal infection and shedding.
Material and methods
Ethics statement
Normal donor cells were acquired from an approved
sub-collection of the Imperial College Tissue Bank. In
vivo experiments were performed in accordance with the
Animals (Scientiﬁc Procedures) Act 1986, and were
approved by the Imperial College Ethical Review Process
panel and the UK Home Ofﬁce.
Bacterial culture
GAS isolates were grown in Todd-Hewitt broth (THB)
(Oxoid, UK) or Columbia horse blood agar. For in vitro
mitogenicity testing, GAS were cultured in RMPI (Life
Technologies) C10% foetal calf serum, and cell-free
supernatants were obtained by 0.25 mM ﬁltering before
co-incubation with cultured human MNC or murine
spleen cells.
Selection of GAS strains for experimental
phenotyping
Lineage C was identiﬁed following a whole genome
sequencing (WGS) study of 442 emm3 invasive and
non-invasive strains from the UK and Ireland, iso-
lated 2001–2013.6 Isolate selection was described by
Al-Shahib et al.,6 and encompassed the upsurge
period, a previous period of enhanced surveillance
and an even distribution across 2001–2013. Pheno-
typic comparisons were limited to ST15 emm3 strains
only, to focus on the novel Lineage C strains. Of the
442 sequenced, 78 were Lineage C ST15 emm3 and
98 were non-Lineage C ST15 emm3 (Fig. 1). All 78
Lineage C strains had lost F315.1 and F315.2 and
65/78 had gained FUK-M3.1, however no FUK-M3.1
negative Lineage C strains were used in any study.
For in vitro study, we selected ST15 isolates carrying
only the superantigens speA, speG and speK in addi-
tion to ssa or speC, from all the ST15 isolates that
had been WGS at that time. This included all ST15
from a collection of 200 emm3 strains of different
STs isolated in 2008–2009 and the previous period of
enhanced surveillance (2003–2004) (as described by
Al-Shahib et al.) plus a further 95 isolates across years
2001–2007 and 2010–2011. The result was 51 Lineage
C strains and 41 non-Lineage strains.
For pilot Galleria mellonella studies, 60 isolates were
originally selected before WGS, and included 42 from
2008–2009 and 18 from 2004 (to act as a pre-upsurge
comparison). Following WGS we able to select only
isolates that were ST15 and excluded any carrying
mutations within the regulatory system covRS, with the
exception of Lineage C strains which all carry a non-
synonymous SNP changing glutamic acid to glycine at
amino acid 252/500 (E252G). No lineage-speciﬁc dif-
ference in the expression of the CovRS positively regu-
lated protease SpeB was observed between Lineage C
and non-Lineage C ST15 strains, as determined by
Western blotting (Fig. S1), suggesting this amino acid
substitution does not affect CovS function.
Two Lineage C ST15 strains (M3-C1, M3-C2) and 2
non-Lineage C ST15 strains (M3–1, M3–2) were selected
for murine in vivo work as representatives of each type
(Fig. S2), blind to any phenotypic data, and paired based
on fewest number of SNPs outside of Lineage-associated
SNPs. These 4 strains do not carry mutations within
known virulence related genes and regulators (CovRS,
Rgg1–4, FasABCX, RivR) with the exception of the CovS
Figure 1. Phylogenetic representation of the ST15 emm3 popula-
tion. Within the ST15 population (indicated in black) was the iden-
tiﬁed epidemic Lineage C ST15 (indicated in red), characterized by
the unique prophage proﬁle; F315.1 and F315.2 are absent in all
78 Lineage C strains and 65/78 carried FUK-M3.1 with speC and
spd1. The short reads for 172 ST15 isolates6 were mapped to the
ST15 reference strain MGAS315 and concatenated SNPs from the
core genome (excluding all prophage regions) were used to gen-
erate the maximum likelihood phylogenetic tree with RAxML7.
2 B. AFSHAR ET AL.
E252G found in M3-C1 and M3-C2, and all other Line-
age C strains.
Western blot analysis
Overnight THB culture supernatant from Lineage C and
non-Lineage C ST15 GAS strains was 0.25 mM ﬁltered
before concentrating 16-fold using TCA precipitation.
Proteins were separated by 10% Bis-Tris LDS-PAGE
(Life Technologies) and immunoblotted using rabbit
anti-SPEC antibody (Toxin Technology), rabbit anti-
SPEB antibody (Toxin Technology) or rabbit anti-SPEA
C-terminal antibody. Quantiﬁcation of SPEC was per-
formed using densitometry (ImageJ) and protein con-
centration calculated by comparison with standard
concentrations of recombinant SPEC (Toxin Technol-
ogy). No lineage-associated differences between Lineage
C and non-Lineage C strains were observed for SPEA
and SPEB expression (Fig. S1).
Pilot Galleria mellonella (waxmoth larvae) virulence
assay
To screen for overall virulence differences, survival
assays were conducted with groups of 10 Galleria mello-
nella larvae (Livefoods Direct Ltd, Shefﬁeld, UK) infected
with each of 7 non-Lineage C ST15 emm3 strains or each
of 5 Lineage C-associated ST15 emm3 strains. Larvae
were injected via the bottom left proleg (105–106 CFU/
larvae) and incubated overnight at 37C. Larvae were
scored for survival at 14h, 24h, then daily up to 120h.
The entire experiment was repeated on a second batch of
larvae.
DNase activity
Overnight THB culture supernatant from ST15 GAS iso-
lates was 0.25mM ﬁltered and inoculated into wells cut
into methyl green agar (Oxoid). Plates were incubated
overnight at 37C and the diameter of DNA hydrolysis
was measured. Activity was calculated by comparison
with known dilutions of DNase I (Life Technologies). All
samples were tested in duplicate.
Mitogenicity assays
Proliferation of human MNC or spleen cells from
HLA-DR4 (Taconic) or HLA-DQ8 transgenic human-
ized mice was measured based on tritiated thymidine
uptake after 72h co-incubation with 1:100 diluted ﬁl-
tered bacterial culture supernatant, recombinant
superantigen, 10% mouse sera or infected tissue as
described previously.8
Recombinant expression and puriﬁcation of SPEC
and SSA
Recombinant SPEC and SSA were expressed using
pGEX-2T constructs kindly provided by Thomas Proft
(University of Auckland)9,10 and puriﬁed from IPTG-
induced BL21 E. coli via GSH-agarose columns. The
GST fusion protein was removed from rSPEC and rSSA
by 5 mg/ml 3c protease or trypsin.9
Murine intramuscular infection
HLA-DQ8 female mice were infected intramuscularly
(thigh) with 106 – 107 (50ml) CFU of GAS and after 24h
of infection, mice were killed. Blood was taken by cardiac
puncture. Spleen, liver, local draining lymph node and
infected thigh muscle were excised, individually weighed
and homogenized in sterile PBS before plating to quan-
tify viable bacterial counts. Serum was collected by cen-
trifugation and stored together with infected thigh tissue
homogenate at ¡20C for mitogenic activity and cyto-
kine analysis.
Murine intranasal infection and shedding
An inoculum of 106 – 107 CFU in 10 ml was adminis-
tered to female HLA-DQ8 mice via the intranasal route
under brief isoﬂurane anesthesia. Nasal shedding of GAS
was monitored daily for 7 d using a nose-pressing tech-
nique.11 To detect airborne shedding of GAS within
cages of infected mice, CBA plates were placed in the
upper rack of the individually HEPA-ﬁltered cages
(4 plates per cage) and exposed for 4h as described previ-
ously.11 Plates were then incubated overnight at 37C,
5% CO2 and the number of GAS colonies (identiﬁed by
b-hemolysis and Lanceﬁeld grouping) recorded. This
procedure was repeated every 24h for 4 d. For histopa-
thology, the entire nasopharynx was removed, ﬁxed in
formalin and processed as described previously.11
Inﬂammation was scored by a blinded histopathologist
(KS).
Cytokine and chemokine measurement
Murine cytokines/chemokines were measured in infected
serum, nasal tissue and thigh tissue homogenate using a
mouse cytokine Luminex 20-plex panel (Life Technolo-
gies) and analyzed on a Bio-Rad Bio-Plex 200 system.
Construction of allelic exchange mutants
To construct speC exchange mutants, a 670bp region
directly upstream of the speC gene was ampliﬁed (forward
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primer: 50 – GGGGTACCAACTATTTTGATGATGTTAAT
C, reverse primer: 50 –CGGAATTCCCATATCCAACTG-
CAAGATAG) incorporating KpnI and EcoRI restriction
sites at either end and cloned into the suicide vector pUC-
MUT upstream of the aphA3 kanamycin resistance cassette.
A 643bp region directly downstream of the speC gene was
ampliﬁed (forward primer: 50 – AAAACTGCAGGAAG
TCCATCGCATGCCGAC, reverse primer: 50 – ACGCGTC-
GACAGTCATTTCGATATTTATCTTG) incorporating PstI
and SalI restriction sites at either end and cloned into pUC-
MUT downstream of the aphA3 kanamycin resistance cas-
sette. Similarly, to construct spd1 exchange mutants, a
685 bp region directly upstream of spd1 was ampliﬁed (for-
ward primer: 50 – GGGGTACCTGCGTCAACAGTTATTG
TCG, reverse primer: 50 – CGGAATTCCACATTAGCCT
CGTTCACGC) and cloned in pUCMUT upstream of the
aphA3 kanamycin resistance cassette. A 711 bp region
directly downstream of spd1was ampliﬁed (forward primer:
50 – AAAACTGCAGCCGCTTACATAAGGAGAAG, rever
se primer: 50 – ACGCGTCGACCTCCAAATATCAACCTT-
GAC) and cloned into pUCMUT downstream of the aphA3
kanamycin resistance cassette creating pUCMUTspd1. The
resultant vectors pUCMUTspeC and pUCMUTspd1 were
then introduced into 2 different Lineage C ST15 emm3
strains (M3-C1 and M3-C2) by electroporation, selected by
400 mg/ml kanamycin and allelic exchange conﬁrmed by
PCR and Sanger sequencing. To construct a combined speC
and spd1 double exchange mutant the region upstream of
spd1 and the region downstream of speC were cloned either
side of the pUCMUT aphA3 cassette and introduced into
Lineage C ST15 emm3 strain M3-C1. Mutagenesis was con-
ﬁrmed by PCR and Sanger sequencing. M3-C1 derivatives,
M3-C1DspeC, M3-C1Dspd1 and M3-C1DspeC/spd1, were
also subjected to whole genome sequencing (NCBI
accession numbers SAMN05818659, SAMN05818
660, SAMN05818661) which conﬁrmed no other genetic
changes had occurred compared with the M3-C1 parent
strains except the targetedmutations.
Assessment of iGAS patient outcome
Of the 442 whole genome sequenced emm3 collection
isolated 2001–2013,6 297 strains were from invasive
disease cases. Laboratory records routinely obtained
from patients in England with invasive GAS infection
were submitted to the NHS Demographic Batch Trac-
ing service to identify deaths, in accordance with
approvals held by Public Health England. Results
from the tracing were used to calculate 7 and 30 day
case fatality rates based on the date culture positive
specimens were taken. Data were then linked to strain
sequence type and genome lineage. Lack of sufﬁcient
patient identiﬁers prevented the acquisition of mortal-
ity data for some cases.
Statistical analysis
All statistical analyses were performed using GraphPad
Prism software version 6.0 for windows; San Diego
California USA. A p-value of  0.05 was considered
signiﬁcant.
Results
The FUK-M3.1 prophage increased the mitogenicity
and DNase activity of Lineage C strains
The loss and acquisition of prophages had altered the
superantigen and DNase complement of Lineage C ST15
strains compared with typical non-Lineage C ST15 strains.
All Lineage C strains had lost the prophage F315.2 with
the superantigen ssa, but the majority had also gained the
prophage FUK-M3.1 which carries a superantigen, speC
and a DNase, spd1. In vitro expression of SPEC by Line-
age C strains was conﬁrmed and measured by quantitative
western blotting (median: 165 ng/ml, range: 81–377 ng/
ml, n D 18 tested). Enhanced mitogenic activity toward
human cells was detected in broth culture supernatant
from Lineage C ST15 strains (all with FUK-M3.1-speC)
compared with non-Lineage C ST15 strains (Fig. 2A),
despite the presence of the superantigen gene ssa in the
latter non-Lineage C strains. We identiﬁed no difference
in SPEA production, measured by western blot, between
Lineage C and non-Lineage C associated strains (Fig. S1)
In vitro DNase activity of Lineage C ST15 strains was
also found to be greater compared with non-Lineage C
ST15 strains (Fig. 2B). Furthermore, both mitogenic
activity (Fig. 2C) and DNase activity (Fig. 2D) were
reduced when deletions were made in speC or spd1,
respectively, in 2 different Lineage C ST15 strains
(M3-C1 and M3-C2) conﬁrming that the activity was
attributable to these genes.
Evaluation of Lineage C strains during invasive
infection in a superantigen-sensitive model
Although the superantigen SPEC is preferentially pre-
sented to T cells by HLA-DR rather than HLA-DQ12,13
pilot studies showed that splenocytes from mice express-
ing HLA-DQ8 were more sensitive to SPEC than mice
expressing HLA-DR4 (not shown). Spleen cells from
HLA-DQ8 mice proliferated in response to SPEC in a
dose-responsive manner, albeit at concentrations that
were 3–4 orders of magnitude greater than concentra-
tions required for human mononuclear cell (MNC)
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response (Fig. 3A). In contrast, both human cells and
mouse cells responded poorly to SSA.
Having established that HLA-DQ8 transgenic mice
can respond to SPEC, we infected HLA-DQ8 mice
intramuscularly with emm3 ST15 strains that were
representative of either Lineage C or the non-Lineage
C. Tissue bacterial burden was not different between
the 2 strains (Table S1), suggesting strains associated
with Lineage C were not inherently more invasive
than other ST15 strains. This was consistent with
pilot experiments that screened multiple lineages of
emm3 GAS in Galleria mellonella, an invertebrate
model previously used effectively to screen for aggres-
sive disease phenotypes.14,15 These preliminary studies
showed wide variation in lethality but no particular
association of Lineage C isolates with virulence;
indeed, there was a trend for reduced lethality associ-
ated with Lineage C when compared with non-lineage
C ST15 isolates (Fig. S3).
Mitogenic activity in the thigh tissue and sera of mice
infected with a Lineage C strain (M3-C1) was signiﬁ-
cantly greater than non-Lineage C ST15 strain (M3–1)
infected mice, conﬁrming production of bioactive super-
antigen in vivo (Fig. 3B). Despite this, HLA-DQ8 mice
did not generate a cytokine/chemokine response to
SPEC that matched the observed difference in bioactive
mitogen detected following infection (Tables S2 and S3).
Both groups of mice produced a general cytokine/che-
mokine response to infection compared with uninfected
mice.
Figure 2. Lineage CST15 emm3 strains have greater DNase activity and enhanced mitogenicity compared with non-Lineage CST15
strains. (A) Human MNC proliferation was greater in response to broth culture supernatant of Lineage C ST15 strains (with FUK-M3.1-
speC) (red, n D 51) compared with non-Lineage C ST15 strains (with F315.2-ssa) (blue, n D 41). Data represent counts per minute
(cpm) of thymidine incorporation of a single human MNC donor minus the background level (delta cpm). All emm3 strains carried addi-
tional superantigens speA, speG, speK and the non-functional M3-smeZ. The experiment was repeated with a second donor and gave
similar results. (B) DNase activity was greater in culture supernatant of Lineage C ST15 strains (with the FUK-M3.1-spd1) (red, n D 51)
than non-Lineage C ST15 strains (blue, n D 41). Data represent DNase activity in units per ml of culture supernatant calculated relative
to a standard. ; p  0.0001 (Mann-Whitney). Horizontal line represents the median (C) Human MNC proliferation was reduced in
response to culture supernatant of Lineage C ST15 strains M3-C1 and M3-C2 when speC was deleted by mutagenesis (M3-C1DspeC and
M3-C2DspeC, white bars) compared with wild-type parental strains M3-C1 and M3-C2 (black bars). (D) DNase activity was reduced in cul-
ture supernatant of Lineage C ST15 strains M3-C1 and M3-C2 when spd1 was deleted by mutagenesis (M3-C1Dspd1 and M3-C2Dspd1,
white bars) compared with wild-type parental strains M3-C1 and M3-C2 (black bars). Data represent the mean of 3 experimental repeats
(Cstandard deviation).
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Enhanced nasopharyngeal shedding of Lineage C
strains during nasopharyngeal infection
Having established, experimentally, that Lineage C did
not demonstrate increased invasiveness, experiments were
conducted to evaluate ﬁtness in nasopharyngeal infection
again using HLA-DQ8 mice that are known to be sensi-
tive to streptococcal superantigens.16 HLA-DQ8 mice
were infected intranasally with either a Lineage C ST15
strain (M3-C1) or a non-Lineage C ST15 strain (M3–1).
Nasal shedding of GAS was longitudinally monitored
over 7 d by nose press as described previously.11 Mice
infected with M3-C1 shed GAS for a longer period of
time compared with mice infected with M3–1 (Fig. 4A)
and nasally shed greater numbers of GAS on days 2 and 3
(Fig. 4B). Airborne shedding of GAS was also monitored
in each cage and, from day 2, greater numbers were
detected in the cage of M3-C1 infected mice compared
with the cage of M3–1 infected mice (Fig. 4B). The pro-
longed nasal and greater airborne GAS shedding demon-
strated by Lineage C M3-C1 compared with non-Lineage
C M3–1 was maintained even when mice were infected
with a 10-fold lower dose (»106 CFU) (Fig. S4).
Similar results were obtained using a different pair of
M3 strains, M3–2 and M3-C2. Mice infected with Line-
age C strain M3-C2 demonstrated prolonged nasal shed-
ding compared with the non-Lineage C strain M3–2
(Fig. 4C). Although, in this instance, the number of nasal
GAS shed by each mouse was not statistically signiﬁ-
cantly different between the 2 strains (Fig. 4D), greater
numbers of airborne GAS shedding were detected when
mice were infected with the Lineage C strain compared
with the non-Lineage C strain (Fig. 4D).
To determine the mechanism that might underlie
prolonged nasal shedding, sections of the nasophar-
ynx were examined after 2 d of infection by a histo-
pathologist (KS) and scored. Six of the 8 mice
infected with non-Lineage C ST15 strains (M3–1 or
M3–2) demonstrated no inﬂammation within the
nasal cavity (Fig. 5A and C). In contrast, both Line-
age C strains (M3-C1 or M3-C2) induced inﬂamma-
tory changes in the nasal cavity (Fig. 5B) with
moderate to marked rhinitis present in the majority
of infected mice (6/8) (Fig. 5C).
Enhanced nasal and airborne shedding of Lineage C
strains is in part due to DNase spd1
The prolonged nasal shedding and enhanced inﬂamma-
tion associated with Lineage C strains raised the possibil-
ity that the superantigen SPEC or the DNase may be in
part responsible for this. Allelic replacement of speC or
spd1 was undertaken in the Lineage C strain M3-C1 to
generate M3-C1DspeC and M3-C1Dspd1. Despite dele-
tion of speC, nasal shedding of GAS (Fig. 6A) and num-
ber of nasal GAS shed (Fig. 6B) by infected mice
remained unaffected. Airborne shedding of GAS likewise
was unaffected by deletion of speC (Fig. 6B). In contrast,
although deletion of the DNase spd1 did not affect the
length of time nasal shedding occurred (Fig. 6C), it
reduced the number of nasal shed GAS on day 2 by
»3-fold (Fig. 6D) and reduced airborne shedding by »5
and »10-fold on days 2 and 3 respectively (Fig. 6D).
Deletion of both speC and spd1 combined in M3-C1 also
reduced airborne shedding (Fig. S5). To support these
ﬁndings, deletion mutants of speC and spd1 were also
Figure 3. SPEC is more potent than SSA in both human and
murine HLA-DQ8 transgenic cell culture and in vivo. (A) Human
MNCs were stimulated with recombinant SPEC (red dotted line,
left axis) or SSA (blue dotted line, left axis) at increasing concen-
trations and compared with murine splenocytes from HLA-DQ8
transgenic mice also stimulated with SPEC (red solid line right
axis) or SSA (blue solid line, right axis). Data represent the mean
( § standard deviation) of a single human donor measured in
triplicate or splenocytes from 3 mice measured in triplicate.
Human MNC data were reproduced in one other donor. (B) To
see if this would be replicated in vivo, human MNCs were stimu-
lated with infected thigh tissue (circles) or sera (squares)
obtained from HLA-DQ8 mice after 24 h of infection with a non-
Lineage C associated ST15 strain M3–1 (blue) or a Lineage C asso-
ciated ST15 strain, M3-C1 (red); 8 mice per strain. A greater mito-
genic response was observed when human MNCs were exposed
to thigh or serum from mice infected with a Lineage C strain
compared with a non-Lineage C strain. Control; uninfected
mouse thigh tissue (black circles) or uninfected mouse serum
(black squares). ; p  0.0001 (Mann-Whitney). Each data point
represents the mean of an individual mouse sample measured in
triplicate. Horizontal lines represent the median.
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constructed in the second Lineage C strain M3-C2 yield-
ing similar results consistent with an impact of spd1 on
airborne shedding (Fig. S6).
Clinical severity phenotype associated with Lineage
C strains
To determine if our in vivo ﬁndings related to clinical
disease during the upsurge, we submitted all 297 emm3
invasive diseases cases (from the total of 442 sequenced
isolates) (2001–2013) for patient outcome tracing.
Patient status was available for 209 of the isolates, of
which 58 were identiﬁed as having died within 7 d of
diagnosis (28%) and 67 within 30 d (32%) (Table S4).
Case fatality rates were similar in patients infected with
emm3 ST15 strains compared with other emm3 STs both
at 7 d (26% v 29%; x2(1 df) D 0.1790, p D 0.672) and 30 d
(32% v 32%; x2(1 df) D 0.0183, p D 0.892) after diagnosis.
Patients infected with Lineage C ST15 strains had slightly
reduced survival than patients infected with non-Lineage
C ST15 strains, although this did not reach statistical sig-
niﬁcance either at 7 d (28% v 24%; x2(1 df) D 0.1740, p D
0.677) or 30 d (35% v 29%; x2(1 df) D 0.4236, p D 0.515)
after diagnosis.
Discussion
The UK-wide upsurge in emm3 iGAS was largely
accounted for by a new epidemic Lineage (Lineage C) of
ST15 emm3, characterized by a different prophage pro-
ﬁle associated with the loss of ssa and gain of speC and
spd1.6 Despite a very high overall 30 day mortality
observed due to emm3 GAS, in this study we have shown
that Lineage C was not inherently more invasive or
lethal. Instead, Lineage C strains were better able to cause
prolonged nasopharyngeal infection and airborne shed-
ding. Furthermore, we identiﬁed a potential role for the
prophage-associated DNase Spd1 in airborne spread.
The presence of prophage FUK-M3.1 in Lineage C
conferred increased mitogenicity, linked to SPEC pro-
duction, and increased DNase activity in vitro and also
in vivo. Streptococcal superantigens result in T cell
activation through cross-linking of MHC class II and
the T cell receptor (TCR) variable b subunit. Although
Figure 4. Nasopharyngeal infection with Lineage C strains resulted in prolonged nasal shedding and enhanced airborne shedding. Mice
infected intranasally demonstrated direct nasal shedding of GAS over a longer period of time when infected with Lineage C strains (A)
M3-C1 (red line) or (C) M3-C2 (red line) compared with mice infected with ST15 strains (A) M3–1 (blue line) or (C) M3–2 (blue line).
Direct nasal shedding was monitored by daily nose press. ; p D 0.0167 (A) or ; p D 0.0062 (C) (Mantel-Cox Log-rank test). (B) Nasal
shedding of GAS by each mouse was signiﬁcantly greater in mice infected with M3-C1 (red line) compared with M3–1 (blue line) on
day 2 (p D 0.0122) and day 3 (p D 0.021) of infection. Airborne shedding of GAS was also signiﬁcantly greater in the cage of mice
infected with M3-C1 compared with the cage of mice infected M3–1 on days 2 (p D 0.0294) and 3 (p D 0.0256). (D) Nasal shedding of
GAS by each mouse was no different between those infected with M3-C2 compared with M3–2 but airborne shedding of GAS was sig-
niﬁcantly greater in the cage of mice infected with M3-C2 compared with the cage of mice infected M3–3 on day 2 (p D 0.0294). ; p 
0.05 (Mann-Whitney). N D 7 per group. Nasal and airborne shedding data represent mean ( § SEM).
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mice are poorly responsive to superantigens, HLA
class II transgenic mice can provide a superantigen-
responsive model.16 To determine if SPEC might be
responsible for increased disease due to Lineage C, we
used HLA-DQ8 mice; contrary to published reports,17
spleen cells from mice expressing HLA-DQ8 could
respond to SPEC, although the threshold for response
was much greater than that demonstrated by human
cells. As HLA-DR4 mice were unresponsive, the model
represented the best available system to explore the
potential role of SPEC during infection. Comparing
non-isogenic, paired ST15 strains, we found no clear
evidence that Lineage C was more invasive than non-
Lineage C ST15 strains, consistent with the Galleria
mellonella studies and clinical and epidemiological
data. In contrast, we found that nasopharyngeal infec-
tion caused by Lineage C resulted in more prolonged
nasal shedding, more abundant nasal shedding, and
more airborne shedding of GAS than non-Lineage C
strains.
Production of SPEA by emm18 GAS was recently
linked to increased nasopharyngeal inﬂammation in
HLA DQ8CDR4 transgenic mice17 and we therefore
hypothesized that the phenotype observed was due to
SPEC production. Unexpectedly, deletion of speC in 2
Lineage C-associated emm3 strains did not alter naso-
pharyngeal shedding or airborne shedding. The emm3
strains used in the current study also carry the super-
antigens speA, speK, speG and smeZ, however a con-
served deletion in the emm3 smeZ results in a
pseudogene that is non-functional as a mitogen.8 As
HLA-DQ8 mice are highly sensitive to the streptococ-
cal superantigens SPEA and SMEZ16,18 it is possible
that any effect of SPEC was obscured by a much
greater response to SPEA that is produced by both
Lineage C and non-Lineage C strains in equal
amounts. It seems likely that, in humans, the impact
of SPEC on pharyngeal inﬂammation may be greater
than we are able to demonstrate in the mouse model
that has limited sensitivity to SPEC.
Figure 5. Nasopharyngeal infection with Lineage C associated ST15 strains resulted in enhanced nasal mucosal damage. Four mice were
infected intranasally for 2 d with either one of 2 ST15 strains, M3–1 or M3–2, or one of 2 Lineage C-associated ST15 strains, M3-C1 or
M3-C2. (A) and (B) photomicrographs of haemotoxylin and eosin stained nasal cavity sections following infection with either a non-Line-
age C ST15 strain (A) or a Lineage C ST15 strain (B). Damage to the nasal mucosa with surface neutrophilic exudate was observed follow-
ing Lineage C strain infection. (C) Semi quantitative histopathological analysis of all sections was performed to assess the damage to the
nasal cavity based on level of rhinitis and associated neutrophilic exudate within the nasal cavity. CCC; marked, CC; moderate, C;
mild, ¡; no abnormality. Each row in each column represents an individual infected mouse. Free and phagocytosed bacteria were
observed in all sections that scored above ‘no abnormality’.
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Surprisingly deletion of FUK-M3.1-associated spd1
reduced airborne shedding, suggesting it may have
played some role in the Lineage C nasopharyngeal
infection phenotype. We predict that spd1 expression
is tightly associated with prophage induction, there-
fore accurate phenotype restoration may not be
achieved with genetic complementation of the mutant.
Reduction of airborne shedding was observed after
nasopharyngeal infection with 2 different spd1-deleted
Lineage C strains, and deletion of both speC and spd1
conﬁrmed this pattern. No other genetic changes
were detected in the mutant strains compared with
the parent strain. Others have shown that DNase is
expressed during upper respiratory infection and may
contribute to disease progression.19,20 The exact role
for spd1 in nasopharyngeal infection is unclear at this
stage and is a subject of on-going work.
We considered the possibility that other genetic
changes in Lineage C might account for the profound
nasopharyngeal carriage phenotype. Prophage F315.1,
which is absent in Lineage C strains compared with other
ST15 strains, is not associated with any known virulence
factors, but it lies within the only clustered regularly
interspaced short palindromic repeat (CRISPR) region
found in emm3 strains, and may render the CRISPR/cas
system inactive.21 In addition to providing prokaryotic
immunity to invading DNA, the CRISPR/cas system
may also be involved in regulation of virulence gene
expression,22 hence a possible impact of F315.1 presence
or absence on virulence cannot be ruled out.
The sudden but transient nature of the upsurge sug-
gested that introduction of the new prophage may have
provided an advantage for Lineage C that could not be
sustained, perhaps due to changes in population suscep-
tibility. Lineage C may also not have been able to com-
pete with other dominant non-emm3 lineages such as
emm1 or the emergent variant of emm89 that were
increasingly dominant in 2008–9.1
The emergence of Lineage C in the UK was not associ-
ated with increased mortality compared with other
emm3 lineages, but was associated with a rise in invasive
cases. There was a rise in scarlet fever notiﬁcations just
before the 2008–9 upsurge23 and we speculate that
increased non-invasive disease abundance in the com-
munity is the most likely basis for the observed rise in
invasive disease; the experimental phenotype of Lineage
C in the nasopharynx provides one explanation for a ﬁt-
ness advantage.
Figure 6. The DNase Spd1 contributes to nasal and airborne shedding of Lineage C strains. HLA-DQ8 transgenic mice were infected
intranasally with either the parental wild-type strain (M3-C1, red line) or the speC deleted strain of M3-C1 (M3-C1DspeC black line) and
nasal shedding was monitored daily over a period of 7 d (A) along with the number of nasal GAS shed by each mouse and airborne
GAS shed (B). N D 8 per group. HLA-DQ8 transgenic mice were also infected intranasally with either the parental wild-type strain (M3-
C1, red line) or the spd1 deleted strain of M3-C1 (M3-C1Dspd1, black line) and nasal shedding was monitored daily over a period of 7 d
(C) along with the number of nasal GAS shed by each mouse and airborne GAS shed (D). N D 7 per group. Deletion of speC had limited
effect on the nasal infection with, in fact an increase in airborne GAS shedding of M3-C1DspeC on day 1 (p D 0.0286). Deletion of the
DNase spd1 signiﬁcantly reduced the number of nasal GAS shed by each mouse on day 2 and reduced airborne GAS shedding on days
2 (p D 0.0284) and 3 (p D 0.0275). ; p  0.05 (Mann-Whitney). Nasal and airborne shedding data represent mean
( § SEM).
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Notwithstanding the lack of any speciﬁc association of
Lineage C with increased severity, invasive disease due to
emm3 GAS overall had an extremely high attendant
mortality of around 30% at 7 d in this study, exceeding
that reported for emm1 iGAS.24 The reasons for the
excessive mortality attributable to emm3 remain
unknown, but underline the importance of better under-
standing the factors that govern emm3 disease abun-
dance within the wider population.
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